← Open Payments lookup

ASSAD MUJTABA: Open Payments

NPI 1699230359 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$303 in 13 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $388 · 2025 $303

Food & beverage: $303
CompanyPaymentsAmount
REVANCE THERAPEUTICS, INC.1$102
Novo Nordisk Inc3$59
Amgen Inc.2$33
ABBVIE INC.2$32
Intra-Sana Laboratories2$29
Teva Pharmaceuticals USA, Inc.1$18
Antares Pharma, Inc.1$16
Madrigal Pharmaceuticals1$16

Products named: DAXXIFY, Ozempic, OTEZLA, QULIPTA, RELTONE 200 MG, AUSTEDO XR, XYOSTED, REZDIFFRA.

Industry payments across NJ — which companies pay providers there.